| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | HORIZON PHARMA PLC | 8,956,988 | 144,924,000 | 5.96% | ||
| 2 | NXSTAGE MED INC COM | 4,258,196 | 111,607,000 | 4.59% | ||
| 3 | AVEXIS INC COM | 2,236,701 | 106,758,000 | 4.39% | ||
| 4 | PORTOLA PHARMACEUTICALS INC | 4,654,447 | 104,446,000 | 4.30% | ||
| 5 | GW PHARMACEUTICALS PLC | 928,192 | 103,725,000 | 4.27% | ||
| 6 | HORIZON PHARMA INVT LTD | 82,600,000 | 78,342,000 | 3.22% | PRN | |
| 7 | AERIE PHARMACEUTICALS INC | 1,838,829 | 69,600,000 | 2.86% | ||
| 8 | MYLAN N V | 1,766,378 | 67,387,000 | 2.77% | ||
| 9 | ARRAY BIOPHARMA INC 3 06/01/2020 | 45,000,000 | 62,545,000 | 2.57% | PRN | |
| 10 | DBV TECHNOLOGIES | 1,743,229 | 61,240,000 | 2.52% | ||
| 11 | VANDA PHARMACEUTICALS INC COM | 3,424,676 | 54,624,000 | 2.25% | ||
| 12 | NEVRO CORP | 751,298 | 54,589,000 | 2.25% | ||
| 13 | XENCOR INC COM | 2,020,000 | 53,166,000 | 2.19% | ||
| 14 | BLUEPRINT MEDICINES CORP COM | 1,842,415 | 51,680,000 | 2.13% | ||
| 15 | ENDOLOGIX INC | 51,117,000 | 46,140,000 | 1.90% | PRN | |
| 16 | ANTHEM INC | 318,000 | 45,719,000 | 1.88% | ||
| 17 | LANNET INC COM NEW | 2,007,551 | 44,266,000 | 1.82% | ||
| 18 | FLAMEL TECHNOLOGIES SA SPONSORED ADR | 4,072,809 | 42,316,000 | 1.74% | ||
| 19 | WRIGHT MED GROUP INC | 40,050,000 | 41,818,000 | 1.72% | PRN | |
| 20 | TRIB | 48,000,000 | 40,401,000 | 1.66% | PRN | |
| 21 | HUMANA | 198,000 | 40,398,000 | 1.66% | ||
| 22 | UNIVERSAL AMERN CORP NEW | 3,774,090 | 37,552,000 | 1.55% | ||
| 23 | ENDOLOGIX INC | 40,500,000 | 35,425,000 | 1.46% | PRN | |
| 24 | CENTENE CORP DEL | 603,643 | 34,112,000 | 1.40% | ||
| 25 | ISIS PHARMACEUTICALS INC DEL | 33,186,000 | 33,802,000 | 1.39% | PRN | |
| 26 | HEALTHWAYS INC | 25,000,000 | 32,381,000 | 1.33% | PRN | |
| 27 | AETNA INC NEW | 242,000 | 30,010,000 | 1.23% | ||
| 28 | NEVRO CORP | 27,600,000 | 29,494,000 | 1.21% | PRN | |
| 29 | WALGREENS BOOTS ALLIANCE INC | 355,957 | 29,459,000 | 1.21% | ||
| 30 | MOLINA HEALTHCARE INC | 25,000,000 | 28,480,000 | 1.17% | PRN | |
| 31 | EHEALTH INC COM | 2,640,609 | 28,122,000 | 1.16% | ||
| 32 | EDITAS MEDICINE INCORPORATED | 1,709,400 | 27,744,000 | 1.14% | ||
| 33 | GALAPAGOS NV | 423,112 | 27,160,000 | 1.12% | ||
| 34 | GLOBUS MED INC | 1,036,000 | 25,703,000 | 1.06% | ||
| 35 | Audentes Therapeutics, Inc. | 1,403,653 | 25,645,000 | 1.06% | ||
| 36 | SYROS PHARMACEUTICALS INC | 1,812,778 | 22,043,000 | 0.91% | ||
| 37 | Ascendis Pharma | 1,050,000 | 21,252,000 | 0.87% | ||
| 38 | BIOCRYST PHARMACEUTICALS | 3,237,734 | 20,495,000 | 0.84% | ||
| 39 | MALLINCKRODT PUB LTD CO SHS | 407,000 | 20,277,000 | 0.83% | ||
| 40 | EPIZYME INC COM | 1,601,049 | 19,373,000 | 0.80% | ||
| 41 | FLUIDIGM CORP DEL | 27,715,000 | 19,228,000 | 0.79% | PRN | |
| 42 | BLUEBIRD BIO INCORPORATED | 302,027 | 18,635,000 | 0.77% | ||
| 43 | MYOVANT SCIENCES LTD | 1,496,675 | 18,619,000 | 0.77% | ||
| 44 | MYLAN N V | 450,000 | 17,168,000 | 0.71% | Call | |
| 45 | CLOVIS ONCOLOGY INC NOTE | 16,500,000 | 16,979,000 | 0.70% | PRN | |
| 46 | SOCIETAL CDMO INC | 2,075,000 | 16,725,000 | 0.69% | ||
| 47 | AXOGEN INC | 1,838,225 | 16,544,000 | 0.68% | ||
| 48 | ZIMMER BIOMET HLDGS INC | 150,000 | 15,480,000 | 0.64% | ||
| 49 | TESARO INC | 112,200 | 15,089,000 | 0.62% | ||
| 50 | SELECTA BIOSCIENCES INC | 853,205 | 14,632,000 | 0.60% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001140361-17-007402, filed 2017.02.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
